chrisvoncsefalvay/vaers-outcomes huggingface dataset:
body aches; Low grade fever (100.1); head ache; This is a spontaneous report from a contactable consumer, the patient. A 27-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 11:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation.. The patient had no medical history reported. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 at 10:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, at 05:00 the patient experienced low grade fever (100.1), body aches and head ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of low-grade fever (100.1), body aches and head ache were not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
CLIENT REPORTS HIVES AND INTENSE ITCHING AFTER LEAVING THE FACILITY. CLIENT ALSO REPORTED 2 DAYS ALTER (FRIDAY), THE CLIENT WENT INTO MEDICAL PROVIDER AFTER FEELING "WEIRD. CLIENT HAD BLOOD DRAWN AND WAS ALTER CALLED BACK TO THE HOSPITAL TO HAVE SCANS OF LUNGS TO EB SURE SHE DIDN'T HAVE BLOOD CLOTS. D-DIMER WAS HIGH (5 OR HIGHER). CLIENT REPORTED HAVING ISSUES WITH BLOOD FOR WEEKS AFTER.
Approximately 2 weeks after the vaccine, inexperienced deep leg pain.  3 days later I went to the hospital and was diagnosed with a blood clot/DVT.; Approximately 2 weeks after the vaccine, inexperienced deep leg pain.  3 days later I went to the hospital and was diagnosed with a blood clot/DVT.; Approximately 2 weeks after the vaccine, inexperienced deep leg pain.  3 days later I went to the hospital and was diagnosed with a blood clot/DVT.; This is a spontaneous report from a contactable consumer.  A 46-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 25Mar2021 13:00 (Batch/Lot Number: ER2613) as SINGLE DOSE for covid-19 immunisation. Medical history included none. The patient's concomitant medications were not reported. Approximately 2 weeks after the vaccine, inexperienced deep leg pain. 3 days later, the patient went to the hospital and was diagnosed with a blood clot/DVT. AE resulted in: [Emergency room/department or urgent care]. The patient received treatment for the events: Vitals taken, blood work, prescribed blood thinner. The patient underwent lab tests and procedures which included blood test: unknown result on an unspecified date ae treatment= Vitals taken, blood work , investigation: blood clot/dvt on 08Apr2021 3 days later I went to the hospital and  was diagnosed with a blood clot/DVT, investigation: unknown result on an unspecified date ae treatment= Vitals taken, blood work.  The outcome of the event was recovering. The patient does not have COVID prior vaccination, and was not COVID tested post vaccination. The patient has no known allergies.
Received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.
She experienced extremely large swelling of her right arm around the injection site and whole bicep  with a rash in the area as well. She had a low grade fever.  We treated her with an  ice pack directly on the area, Children's Motrin, and Benadryl. The swelling gradually went down over the course of a few days.
Feeling so sick, ¨like if i had Covid again¨; Pain in every joint of her body, including her toes; Head is pounding; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Feeling so sick, ¨like if i had Covid again¨), ARTHRALGIA (Pain in every joint of her body, including her toes) and HEADACHE (Head is pounding) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced ILLNESS (Feeling so sick, ¨like if i had Covid again¨), ARTHRALGIA (Pain in every joint of her body, including her toes) and HEADACHE (Head is pounding). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Feeling so sick, ¨like if i had Covid again¨), ARTHRALGIA (Pain in every joint of her body, including her toes) and HEADACHE (Head is pounding) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included blood pressure medication.   Patient took a pain pill along with Tylenol as treatment for the events.
Woke up on the 4th with still neck and had Vertigo. Saw Dr. about the vertigo on the 8th. Been taking Meclaziine. Vertigo and pain in joints persisted for 7 days. Until, approximately the 10. Vertigo and pain in joints has seemed to go away. Still feeling HEAD FOGGINESS since. Constantly tired.
Fever, malaise. Large-red-swollen painful-inflamed area upper arm 10cm x 10cm. Treatment: ice, BENADRYL, ADVIL.
a week after the second shot I developed Shingles.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ENG6201) via an unspecified route of administration in the a right arm on 03Mar2021 at 15:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot Number: ER6206) via an unspecified route of administration in the right arm on 23Feb2021 at 15:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 24Mar2021, a week after the second shot the patient experienced shingles. The patient also reported that his father in law had the same thing happened to him after the first Pfizer shot. The adverse event resulted in a visit to the doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken and included treatment with valacyclovir. The clinical outcome of the event shingles was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021374076 same reporter/drug/event, different patient
Patient was given 0.2ml of the adult formulation of the Pfizer adult formulation.
This spontaneous report as received from a physician refers to unspecified patients of unknown age and gender. The patient's pertinent medical history, current conditions and concomitant medications were not reported. On an unknown date the patients were vaccinated with improperly stored ROTATEQ (therapy type: Digital data logger) (lot # L035276 with expiry date of 09-JUN-2017), orally, at a temperature of 33 F for a time frame of 8 hrs 20 min cumulatively. The physician reported there was a previous temperature excursion, which was cumulative total since unspecified time in March 2016. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Lightheadedness; Nausea; On and off like weakness in the legs, a little bit more tired; This is a spontaneous report from a contactable consumer (patient). A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9269), dose 1 via an unspecified route of administration on 06Feb2021 as single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included vitamins. On an unspecified date, the patient experienced lightheadedness, nausea and on and off like weakness in the legs, a little bit more tired. The patient had week long symptom. The patient did not had medical condition. The patient was surprised by the link of the symptoms, so she called. The patient did not received treatment. The outcome of the events were unknown.
Very bad sometimes extreme pain in my left breast area  that radiates into my chest area.   Hurts to touch my left breast area and the pain is a shooting pain that is constant and feels like a stabbing pain.  Hurts to move my left arm.  I've been taking 3 Advil at a time and the pain subsides for a couple of hours but comes back.  It doesn't matter if I'm sitting up or lying down the pain is always there.  I sometimes feel like I've had the wind knocked out of me when the pain radiates to the front of my chest area. There is no longer any pain at the injection site.
Patient states she woke up in the middle of night with hives - both RPh & MD instructed patient to take BENADRYL.
Site: Pain at Injection Site-Medium, Systemic: Chills-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Medium, Systemic: Vomiting-Medium, Systemic: Weakness-Medium, Additional Details: Pt received 2nd dose Moderna on 11/10 at 11am. Pt called 11/12 to report intense, significant adverse reactions that began 11/10 4pm & continuued thru 11/11. Pt described: sweating, chills, trembling, pain at injection site w no swelling, arm pain down to wrist, painful to raise arm above head, wrist cramp, arm ache & cramp, restlessness, nausea, vomitting several times. By Fri 11/12, pt states able to eat tea & banana, starting to feel better.  Advised pt to drink water & resume eating.
Chills, fevers of up to 103.2, body aches, malaise, cough,small pustules on skin
feeling "really tired"; sort of weak; muscle pain; Sort of weak, specifically in her legs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021264134 (Pfizer).  A 76 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 03Feb2021 (Lot number: EN5318, Expiration Date: 31May2021) at the age of 76 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing); "acid reflux" (unspecified if ongoing); "cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 05Mar2021, outcome "not recovered", described as "feeling "really tired""; ASTHENIA (non-serious) with onset 05Mar2021, outcome "not recovered", described as "sort of weak"; MYALGIA (non-serious) with onset 05Mar2021, outcome "not recovered", described as "muscle pain"; MUSCULAR WEAKNESS (non-serious) with onset 05Mar2021, outcome "not recovered", described as "Sort of weak, specifically in her legs". Additional information: Patient was a 76-years-old female who received her first dose of the Pfizer BioNTech COVID-19 vaccine on Wednesday (03Feb2021). She stated that yesterday and Thursday she was feeling okay but today reported feeling "really tired" and "sort of weak", specifically in her legs, as well as muscle pain on 05Mar2021.  She would like to know if these symptoms are coming from the vaccine and is concerned about how long they will last. She was not sure if she should get the second dose because of this. She would like to know what would happen if you only got the first dose of the Pfizer BioNTech COVID-19 vaccine. Patient stated she got the COVID vaccine on Wednesday 03Feb2021, stated she had been getting some weakness and feeling tired a lot since then, having some muscle pain, just got the thing Wednesday, yesterday she felt fine and the symptoms started today. She wanted to know when do these symptoms go away.  No follow-up attempts are possible. No further information is expected.
Very sore arm at injection site within 2-3 hours. Developed fever of 99.6°F the morning after injection. Fever/malaise/body aches persisting 24 hours after injection.
This spontaneous report was received from a registered nurse referring to a 11 year old male patient. Information about the patient's pertinent medical history and concurrent conditions was not reported. The patient did not have drug reactions/allergies. On an unknown date, the patient was vaccinated with GARDASIL 9, (dose, route of administration, lot # and expiration date were not provided); and with a meningococcal vaccine (unspecified) (manufacturer unknown) in the same arm. Concomitant medication was not reported. The reporter stated that the patient complained of injection site pain that lasted 3 days, then subsided for a period described as "a couple of weeks". Following the couple of weeks interval, the patient experienced that the injection site pain returned for an unspecified length of time. The outcome of injection site pain was reported as not recovered, also described as "the pain was continuing currently". The reporter did not assess the relatedness between injection site pain and GARDASIL 9. Additional information is not expected since no consent was given to reach follow up.
BODY ACHES; HEADACHE; WEAKNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025 expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced body aches. On 10-MAR-2021, the subject experienced headache. On 10-MAR-2021, the subject experienced weakness. Treatment medications (dates unspecified) included: naproxen sodium, and ascorbic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, headache, and weakness. This report was non-serious.
rash/hives all over her body, rash became worse; rash/hives all over her body; Itching; This is a spontaneous report from a contactable consumer for mother. A 78-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/ Lot number and Expiry date was unknown), via an unspecified route of administration, on 22Jan2021, as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient got her first Pfizer Covid vaccine on 22Jan2021 and her second dose of vaccination was due on 12Feb2021. On 22Jan2021, after 1.5 hours receiving the first dose of vaccination, patient developed a rash/hives all over her body (not much on her face, but all over the rest of her body). Patient's HCP recommended Zyrtec that day for the rash and then overnight it became worse, after then HCP prescribed prednisone and hydrocortisone for the itching and Benadryl. After receiving 4 days of steroids, it started to clear up in about a day or 2. Patient was scheduled for second dose on 12Feb2021 and inquired whether she can receive the dose. The outcome of the event was reported as recovered on unknown date in 2021.  Follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
erectile disfunction; brain fog; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 25-year-old male patient received BNT162b2 (BNT162B2), on 22May2021 at 07:15 as dose 2, single (Lot number: EW0170) at the age of 25 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ASHWAGANDHA. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: Unknown. PFiZer EW0170, Location of injection: Arm Right, Vaccine Administration Time: 10:00 AM), administration date: 01May2021, when the patient was 25-year-old, for Covid-19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 22May2021, outcome "not recovered", described as "brain fog"; ERECTILE DYSFUNCTION (medically significant) with onset 22May2021, outcome "not recovered", described as "erectile disfunction". The patient underwent the following laboratory tests and procedures: several health chekup: reports were fine. Therapeutic measures were not taken as a result of erectile dysfunction, feeling abnormal.  Clinical course: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. He complained of brain fog and erectile disfunction soon after the second dose of vaccination, Pfizer COVID Vaccine. He went for several health check-up and the reports were fine. But the disfunction remained the same.
Patient received her 1st dose of Moderna vaccine and was under the age recommended by the manufacturer and the EU protocol.  She was accompanied to the vaccination clinic with her father who consented for PT to receive her first dose.
Information has been received from a medical assistant concerning a 22 month old female with a medical history of behavior issues, but no drug reactions or allergies, who on 26-FEB-2007 was vaccinated subcutaneously in the left upper thigh, with her first dose of varicella virus vaccine live (Oka/Merck) (Lot#654756/1335F). She was also vaccinated with influenza virus vaccine (unspecified) that same day. On 06-MAR-2007 the patient experienced a red, raised and a little swollen area at the injection site. No lab diagnostic studies were performed. The patient's status at the time of the report was recovering. Unspecified medical attention was sought. There was no product quality complaint. The office requested a lot check on Lot#654756/1335F. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/16/2007. The office requested a lot check on Lot # 634756/1335F. This report is one report of five reported by the same source. A review of the release testing data revealed that the lot in question conformed to all required testing at the time of product release. The lot complies with the standards of the Center and was released. No further information is expected. This is in follow-up to report (s) previously submitted on 5/16/2007.
Not pregnant.  Within about 15 minutes after receiving my 2nd vaccine in my right arm, my left hand swelled up substantially around the knuckle area. It's been over a month since the vaccine and I still have some swelling in the area and arthritic like aching and pain.  Could the vaccine have aggravated an arthritic reaction?
patient was on his scooter and after receiving 2nd of covid 19at one station turned around and pulled in line again at another station to get vaccinated.   Patient had a duplicate  VAR form and immunization card that were not filled out by RPH  . patient received a 3rd dose on the covid 19 vaccine minutes later.
Patient complained of feeling light headed. She said she felt she was having a panic attack. Patient was brought to triage in wheelchair. Patient's vitals taken twice. She sat for 30 minutes and said she felt better then left to go home.
This spontaneous report as received from a nurse refers to unspecified patient of unknown age and gender. No medical history and current conditions were reported. The nurse reported that on an unknown date unknown number of patients were inadvertently vaccinated with PEDVAXHIB (unspecified dose and route) lot # J008427 expiry date 09-APR-2016. On an unspecified date the vaccine had been improperly stored. The outcome of event was unknown. No adverse effects reported. Product quality complaint (PQC) was not reported. No further information provided. This is one of several reports received from the same reporter. Additional information has been requested.
Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drug information was provided by reporter.  No treatment drug information was provided by reporter.   Reporter did not allow further contact
He never went back to get the other two doses; He stated that there was no complications/No further adverse events or product complaints reported; This spontaneous report was received from a consumer regarding his son, a 21-year-old male patient. The patient's pertinent medical history, concurrent condition, concomitant medications, drug reactions and allergies were not reported.   On 02-JUN-2016, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, frequency, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis.  The reporter had a question regarding the vaccine dosing schedule and stated that his son never went back to get the other two doses (inappropriate schedule of product administration). There were no complications and no further adverse events, or product complaints reported (no adverse event).